BSH Guideline: Diagnosis and therapy of genetic haemochromatosis (2017 update)

BSG-endorsed British Society for Haematology (BSH) guidelines on haemochromatosis

Genetic haemochromatosis (GH) is one of the most frequent genetic disorders found in Northern Europeans. GH is a condition caused by continued absorption of iron from the upper small intestine, despite normal, and then increased, total body iron. This leads to accumulation of iron in the tissues as the body has no means of getting rid of excess iron.

In advanced disease, iron accumulation causes widespread tissue damage, including diabetes mellitus and cirrhosis. The disorder is inherited in autosomal recessive fashion. The gene involved lies close to the HLA-A region on chromosome 6. This updated guideline follows on from the previously published guideline commissioned by the British Committee for Standards in Haematology in February 2000 (Dooley & Worwood, 2000). This review and updated guidance coincides with the development of a separate guideline on the investigation and management of a raised serum ferritin, also commissioned by the BSH guidelines committee.

Read More

BSG logo
Clinical Resources
Guidance
Small Bowel and Nutrition
BAPEN Position Statement on Electrolyte and Vitamin Replacement in Adult patients with severe malnutrition, including people with Eating Disorders and other conditions who are undergoing refeeding
clinical-resource/BAPEN-Electrolyte-Vitamin-Replacement
This guidance has been endorsed by the BSG, and was published in 2025.

BSG logo
Clinical Resources Categories
Liver
Venesection treatment in haemochromatosis – current best practice from the BSG/BASL Special Interest Group
clinical-resource/Venesection-treatment-in-haemochromatosis